Showing results (531-540 of 617) with videos related to

Sort By:
Pageof 62
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)Philipp Harter, David Gershenson, Catherine Lhomme, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2013
CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancerXiaoxiang Chen, Jing Zhang, Wenjun Cheng, et al.
JAMA Network Open|June 16, 2023
Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian CarcinomasKoji Matsuo, Shinya Matsuzaki, Michihide Maeda, et al.
Cancer Immunology Research|May 6, 2015
Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric ImmunoreceptorsEnxiu Wang, Liang-Chuan Wang, Ching-Yi Tsai, et al.
Cancer Biology & Therapy|September 14, 2006
Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinomaAparna A Kamat, Farideh Z Bischoff, Dianne Dang, et al.
Cancer|April 8, 2011
Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancerSiqing Fu, Wei Hu, Revathy Iyer, et al.
Cancer Biology & Therapy|September 14, 2006
Analysis of EphA2 expression and mutant p53 in ovarian carcinomaWilliam M Merritt, Premal H Thaker, Charles N Landen, et al.
BMC Cancer|December 20, 2014
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomasAlicia A Tone, Melissa K McConechy, Winnie Yang, et al.
Nature Communications|June 29, 2018
KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovaryR Tyler Hillman, Joseph Celestino, Christopher Terranova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathwayYvonne G Lin, Ajaikumar B Kunnumakkara, Asha Nair, et al.
Pageof 62